ARCHIVES

CMS Issues Coverage Decision For Provenge in Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

NCI-Approved CTEP Trials For the Month of December

December 28, 2012

Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III

June 27, 2014

New NCI Journal Patterned On “Science”

March 20, 1987

Chemoprevention, Immunotoxicolgy RFAs Available

June 5, 1981

Dingell To Challenge NCI, NSABP Handling Of Fraud, Delays

April 8, 1994

NCI Begins Large National Clinical Trial To Validate Biomarker For Lung Cancer

October 31, 2008